Suki announces $90 million financing for healthcare AI agents
Suki announced $90 million in financing on October 13, 2026, as part of its Series E. New investors include Healthier Capital, Crosslink Capital and Hercules Capital, alongside existing institutional backers.
Healthier Capital says it leads the financing. Suki says the firm’s partner Aman Mahajan will join its board.
What the financing supports
The company plans to expand its AI technology, integrations and commercial organization. It reports serving more than 450 healthcare organizations and working with more than 30 technology partners.
The announcement does not disclose a valuation or a breakdown between equity and debt. Its description of financing as part of Series E also leaves the complete round size unspecified.
Ask brings chart data and clinical references together
The financing follows an earlier product release. Suki introduced Ask on October 8, combining patient chart information with UpToDate content in spoken or typed queries. Suki lists mobile, desktop and Chrome extension access. It directs clinicians to their customer success manager or contact team to start using Ask.
Wolters Kluwer’s announcement lists Epic, Oracle Health, athenahealth and MEDITECH compatibility. Clinicians need UpToDate access for its clinical answers, which include source references and links to supporting content and drug monographs.
Suki describes Ask as a retrieval and synthesis tool. Its product explanation says it does not diagnose conditions or prescribe treatment plans, and places responsibility for reviewing information and making care decisions with clinicians.
Two ways to reach healthcare organizations
In the clinician application, Suki describes software that turns conversations into structured notes for the electronic health record. It can also stage orders from a patient conversation for a clinician to review and approve. Other listed features include patient summaries, dictated preparation before a visit and voice editing of notes. These are existing product capabilities.
Its integration documentation describes information moving in both directions. Recent chart information can flow into a note, and the finished note can be sent back to the record. That workflow differs from an assistant that only supplies text for someone to copy into another application.
The second route is Suki for Partners, which lets other healthcare software companies embed the technology. Its software development kits include a prebuilt interface. Its APIs offer more control over the interface and workflow, with functions for generating and submitting notes, retrieving information and personalizing output. Listed partner capabilities also include separating speakers, chart summaries and order staging.
A research plan for clinical use
A separate MedStar Health research announcement sets out plans to study adoption, clinician and patient experience, safety and care quality. The collaboration proposes quantitative and qualitative research in clinical settings, with findings expected to be submitted for scientific publication. That announcement describes a research program. It does not report completed evidence that Suki improves patient outcomes.
Archival digital healthcare illustration from 2014. Photograph by Daniel Sone for the National Cancer Institute, marked public domain. Converted to WebP.
